CORC

在结果中检索

CORC

浏览/检索结果: 共31条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Sustained virologic response (SVR) to direct-acting antiviral (DAA) therapy in patients with chronic hepatitis C virus (HCV) infection and hepatocellular carcinoma (HCC): a systematic review and meta-analysis 会议论文
作者:  Ji, F.;  Wei, M. T.;  Yeo, Y. H.;  Wei, B.;  Ogawa, E.
收藏  |  浏览/下载：3/0  |  提交时间：2019/11/19
Efficacy and safety of paritaprevir/ritonavir/ombitasvir combined with dasabuvir in non-cirrhotic Asian adult patients with newly diagnosed and treated chronic HCV genotype 1b infection: a randomized, double-blind, placebo-controlled study - China data]. 期刊论文
Chinese journal of hepatology, 2018, 卷号: 26, 页码: 359-364
作者:  Wei L;  Cheng J;  Luo J;  Li Z P;  Duan J L
收藏  |  浏览/下载：13/0  |  提交时间：2019/11/19
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir combined with ribavirin in Asian adult patients with chronic HCV genotype 1b infection and compensated cirrhosis]. 期刊论文
Chinese journal of hepatology, 2018, 卷号: 26, 页码: 353-358
作者:  Wei L;  Wang G Q;  Sarah J;  Cheng Q;  Xie M R
收藏  |  浏览/下载：8/0  |  提交时间：2019/11/19
Association of polymorphism rs1053005 in STAT3 with chronic hepatitis B virus infection in Han Chinese population 期刊论文
BMC MEDICAL GENETICS, 2018, 卷号: 19
作者:  Li, Man;  Li, Fang;  Li, Na;  Sang, Jiao;  Fan, Xiude
收藏  |  浏览/下载：2/0  |  提交时间：2019/11/26
Highly elevated soluble Tim-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infection 期刊论文
CANCER MANAGEMENT AND RESEARCH, 2018, 卷号: 10, 页码: 941-951
作者:  Li, Fang;  Li, Na;  Sang, Jiao;  Fan, Xiude;  Deng, Huan
收藏  |  浏览/下载：13/0  |  提交时间：2019/11/26
Association of the tandem polymorphisms (rs148314165, rs200820567) in TNFAIP3 with chronic hepatitis B virus infection in Chinese Han population 期刊论文
VIROLOGY JOURNAL, 2017, 卷号: 14
作者:  Li, Na;  Shi, Ying;  Zhang, Pingping;  Sang, Jiao;  Li, Fang
收藏  |  浏览/下载：6/0  |  提交时间：2019/11/26
Association of genetic variation in B-cell activating factor with chronic hepatitis B virus infection 期刊论文
IMMUNOLOGY LETTERS, 2017, 卷号: 188, 页码: 53-58
作者:  Han, Qunying;  Yang, Cuiling;  Li, Na;  Li, Fang;  Sang, Jiao
收藏  |  浏览/下载：3/0  |  提交时间：2019/11/26
Association of LTBR polymorphisms with chronic hepatitis B virus infection and hepatitis B virus-related hepatocellular carcinoma 期刊论文
INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 卷号: 49, 页码: 126-131
作者:  Zhu, Qianqian;  Li, Fang;  Sang, Jiao;  Deng, Huan;  Han, Qunying
收藏  |  浏览/下载：3/0  |  提交时间：2019/11/26
Telbivudine therapy for gravidas with chronic hepatitis B infection and patients at risk of renal impairment 期刊论文
JOURNAL OF VIRAL HEPATITIS, 2017, 卷号: 24, 页码: 6-11
作者:  Liu, J.;  Chen, T.;  Zhao, Y.
收藏  |  浏览/下载：1/0  |  提交时间：2019/11/26
Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection 期刊论文
ONCOTARGET, 2017, 卷号: 8, 页码: 46020-46033
作者:  Li, Na;  Zhou, Zhihua;  Li, Fang;  Sang, Jiao;  Han, Qunying
收藏  |  浏览/下载：7/0  |  提交时间：2019/11/26

©版权所有 ©2017 CSpace - Powered by CSpace